Details for 2013864403

Up to date per 04.04.2026

Actions

Title / Product Name

4'-FLUOR-NUKLEOSIDE, 4'-FLUOR-NUKLEOTIDE UND ANALOGA DAVON ZUR BEHANDLUNG VON HCV

Status

Granted/Registered

Protection Type

European Patent

(AT-) Application Number

2013864403

EP Publication Number

2935303

E-Number

1361338

Language

PCT Number

US13076740

Publication Date

28.10.2015 A

17.02.2021 B1

Registration Date

17.02.2021

AT Publication Date

15.03.2021

Application Date

19.12.2013

Registration Number

Priorities

21.12.2012

201261745466 P

11.10.2013

201361890125 P

IPC

C07H 19/067 20060101AFI20160707BHEP

Maximum Duration of Protection

19.12.2033

Owner

Janssen BioPharma, Inc.260 E. Grand Avenue, 2nd Floor South San Francisco, CA 94080US

Representative

Häupl & Ellmeyer KG, PatentanwaltskanzleiMariahilfer Straße 50 (Eingang Kirchengasse 1)1070 WienAT

Inventor

BEIGELMAN, Leonid991 East Grant Place San Mateo, CA 94402US

WANG, Guangyi5066 Millay Court Carlsbad, CA 92008US

SMITH, David, Bernard218 W. 40th Avenue San Mateo, CA 94403US

Information about Fees